Effects of dialkoxylphenyl compounds with oxime group on macrophage function and the proliferation of lymphocytes.

about

Akt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effects

P2860

Q33744734-A16E13FF-49F2-4533-AD6C-E0D9F3F8C6BD

P2860

Effects of dialkoxylphenyl compounds with oxime group on macrophage function and the proliferation of lymphocytes.

Item

http://www.wikidata.org/entity/Q44852650

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Effects of dialkoxylphenyl com ...... proliferation of lymphocytes.

@en

Effects of dialkoxylphenyl com ...... proliferation of lymphocytes.

@nl

type

Item

label

Effects of dialkoxylphenyl com ...... proliferation of lymphocytes.

@en

Effects of dialkoxylphenyl com ...... proliferation of lymphocytes.

@nl

prefLabel

Effects of dialkoxylphenyl com ...... proliferation of lymphocytes.

@en

Effects of dialkoxylphenyl com ...... proliferation of lymphocytes.

@nl

P1476

Effects of dialkoxylphenyl com ...... proliferation of lymphocytes.

@en

P2093

Ae Ra Kim

http://www.w3.org/2001/XMLSchema#string

Eun Sook Yoo

http://www.w3.org/2001/XMLSchema#string

Ho Jung Son

http://www.w3.org/2001/XMLSchema#string

Joon Seok Park

http://www.w3.org/2001/XMLSchema#string

Kyong Up Baik

http://www.w3.org/2001/XMLSchema#string

Myung Hwan Park

http://www.w3.org/2001/XMLSchema#string

P2860

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha.

Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFalpha treatment

Etanercept: therapeutic use in patients with rheumatoid arthritis

Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions.

Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation.

Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies.

Synthesis and SAR studies for the inhibition of TNF-alpha production. Part 2. 2-[3-(Cyclopentyloxy)-4-methoxyphenyl]-substituted-1-isoindolinone derivatives.

PDE isoenzymes as targets for anti-asthma drugs.

Noble 2-[3-(cyclopentyloxy)-4-methoxyphenyl]-1-isoindolinone derivatives. part I: synthesis and SAR studies for the inhibition of TNF-alpha production.

P304

503-512

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1211/0022357023042

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jae Youl Cho

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15099445

http://www.w3.org/2001/XMLSchema#string

Effects of dialkoxylphenyl compounds with oxime group on macrophage function and the proliferation of lymphocytes.

about

P2860

P2860

Effects of dialkoxylphenyl compounds with oxime group on macrophage function and the proliferation of lymphocytes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698